Mechanisms of age-related susceptibility to the chikungunya virus (CHIKV)
Mechanisms of age-related susceptibility to the chikungunya virus (CHIKV)
批准号:
9350814
负责人:
JANKO Z. NIKOLICH
金额:
$38.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-15 至 2017-08-31
关键词:
AcuteAfricanAgeAgingAlphavirusAnimalsAntibodiesArthralgiaArthritisAsiansB-Lymphocyte SubsetsB-LymphocytesBrainCD4 Positive T LymphocytesCD8B1 geneCXCL9 geneCaribbean regionCellsCessation of lifeChikungunya virusChronicChronic DiseaseClinicalCodeColorCountryCulicidaeDefectDiseaseElderlyEpidemicExanthemaFeverFloridaFunctional disorderHumanImmuneImmune System DiseasesImmune responseImmunityImpairmentIndividualInfectionInflammationInflammatoryInterferon-alphaInterventionJointsKidneyKnockout MiceLeadLightLiverMeasuresMediatingModelingMorbidity - disease rateMusOrganOrganismOutcomePassive Transfer of ImmunityPathogenesisPathologyPlayPopulationPredispositionProductionRegulationRegulatory T-LymphocyteReportingResolutionRiskRisk FactorsRoleSerumSeverity of illnessSolidSurfaceSwellingSynovial FluidT cell responseT-LymphocyteTestingThickTimeTransforming Growth Factor betaVirusVirus DiseasesWorkadaptive immunityage relatedagedchemokinecytokineimmunopathologyimprovedinsightlymph nodesmacrophagemortalitymouse modelneutralizing antibodypreventresearch studyresponsetransmission processvector mosquitoviral resistancevirus pathogenesis
中文摘要
基孔肯雅病毒(CHIKV)是最近在世界范围内传播的一种新出现的甲型病毒
通过它的蚊子媒介。该病毒极有可能造成严重的发病率和死亡率。
包括美国在内的世界各地,据报道最初的传播是在佛罗里达州。老年人尤其是
对严重的CHIKV疾病(CHIKVD)敏感,包括发烧、皮疹、关节疼痛,有时
实质器官(肝、脑、肾)受累。此外,CHIKVD倾向于在许多地方持续存在,
尤其是年龄较大的受试者,会出现几个月甚至几年的高度衰弱的关节炎/关节痛的形式。而当
我们开始了解CHIKV的发病机制和免疫,我们甚至远远没有抓到
关于与年龄有关的CHIKV易感性的机制。
我们最近开发了一种小鼠模型,它概括了与年龄相关的临床结果。
在感染CHIKV的老年人中观察到的,并用它开始阐明潜在的机制
CHIKV感染所致免疫反应的年龄相关性功能障碍。我们发现产量下降了
CXCL9的表达和转化生长因子β的增加,伴随着B和T质和量的损害
未能清除病毒的细胞反应。我们发现抗转化生长因子β抗体阻断可以
预防增龄性CHIKV疾病严重程度增加,减轻关节病理改善
产生中和抗体。老年患者转化生长因子β也升高,中和抗体降低
人类患有CHIKV,这使得我们的模型可能与老年人直接相关。在这里,我们
建议解剖导致转化生长因子β产生失调的机制,并阐明转化生长因子β是如何
有助于增加病理和降低CHIKV控制。我们的中心假设是,在旧的
CHIKV感染小鼠、转化生长因子β增加和CXCL9水平降低相互作用和/或协同作用
通过作用于Th1、B和Treg细胞来调节对CHIKV的免疫。这一假设和
相关问题和次级假设将在以下目标中进行检验:
目的1.测试适应性免疫中与年龄相关的缺陷是否以及如何有助于
免疫病理学,CHIKV控制不佳,或两者兼而有之。
目的2.阐明转化生长因子β在CHIKV感染过程中如何以及为什么会随着年龄的增长而失控。
目的3.明确转化生长因子β如何损害获得性免疫CHIKV并使关节沉淀
随年龄增长的病理变化。
这些实验将对CHIKV的发病机制和免疫机制提供详细的见解。
在老年生物体中,为老年人CHIKVD/慢性关节炎的免疫干预铺平了道路。
英文摘要
Chikungunya virus (CHIKV) is a reemerging alphavirus that recently spread throughout the world
via its mosquito vectors. The virus has high potential to inflict significant morbidity and mortality
worldwide, including the U.S., with initial transmissions reported in Florida. Older adults are particularly
sensitive to severe CHIKV disease (CHIKVD), which includes fever, rash, joint pain and sometimes
involvement of parenchymal organs (liver, brain, kidney). Moreover, CHIKVD tends to persist in many,
particularly older, subjects in the form of highly debilitating arthritis/arthralgia for months and years. While
we are beginning to understand CHIKV pathogenesis and immunity, we are far from even scratching the
surface on the mechanisms of age-related vulnerability to CHIKV.
We recently developed a mouse model which recapitulates age-related clinical outcomes
observed in CHIKV-infected elderly humans, and used it to begin to elucidate mechanisms underlying
the age-related dysfunction of the immune response to CHIKV infection. We found decreased production
of CXCL9 and an increase in TGFβ, concomitant with qualitative and quantitative impairments in B and T
cell responses which failed to clear the virus. We showed that anti-TGFβ antibody blockade could
prevent the age-related increase in CHIKV disease severity, reduce joint pathology and improve
production of neutralizing antibodies. TGFβ was also elevated and neutralizing Ab reduced in older
humans suffering from CHIKV, making our model potentially directly relevant to older adults. Here, we
propose to dissect mechanisms that lead to dysregulated TGFβ production and to elucidate how TGFβ
contributes to increased pathology and decreased CHIKV control. Our central hypothesis is that in old
CHIKV-infected mice, increased TGFβ and reduced CXCL9 levels interact and/or synergistically
dysregulate immunity against CHIKV by acting upon Th1, B and Treg cells. This hypothesis and
related questions and sub-hypotheses will be tested in the following Aims:
Aim 1. To test whether and how age-related defects in adaptive immunity contribute to
immunopathology, poor CHIKV control or both.
Aim 2. To elucidate how and why TGFβ is dysregulated with aging during CHIKV infection.
Aim 3. To define how TGFβ impairs adaptive immunity CHIKV and precipitates joint
pathology with age.
These experiments will provide detailed insights into pathogenesis and immunity against CHIKV
in old organisms, paving way for immune interventions against CHIKVD/chronic arthritis in older adults.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of CMV in HIV-associated accentuated aging
-
批准号:10760596
-
项目类别:
-
资助金额:$67.25万
-
财政年份:2023
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Mechanisms of age-related susceptibility to the chikungunya virus (CHIKV)
-
批准号:10436970
-
项目类别:
-
资助金额:$33.77万
-
财政年份:2018
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Viral burden and systemic inflammation as biomarkers for chronic disease and frailty in aging
-
批准号:10153615
-
项目类别:
-
资助金额:$65.25万
-
财政年份:2018
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Mechanisms of age-related susceptibility to the chikungunya virus (CHIKV)
-
批准号:10251001
-
项目类别:
-
资助金额:$33.77万
-
财政年份:2018
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Viral burden and systemic inflammation as biomarkers for chronic disease and frailty in aging
-
批准号:10412933
-
项目类别:
-
资助金额:$64.92万
-
财政年份:2018
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Thymic and peripheral Aspects of T cell Aging and Rejuvenation
-
批准号:10226915
-
项目类别:
-
资助金额:$192.44万
-
财政年份:2017
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Project 4: Thymic and peripheral Aspects of T cell Aging and Rejuvenation
-
批准号:10226925
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2017
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Peripheral T cell maintenance defects with aging
-
批准号:10553995
-
项目类别:
-
资助金额:$53.06万
-
财政年份:2017
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Thymic and Peripheral Aspects of T Cell Aging and Rejuvenation
-
批准号:10553988
-
项目类别:
-
资助金额:$271.3万
-
财政年份:2017
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Scientific Integration and Administration
-
批准号:10553989
-
项目类别:
-
资助金额:$15.63万
-
财政年份:2017
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Thymic and peripheral Aspects of T cell Aging and Rejuvenation
-
批准号:9755287
-
项目类别:
-
资助金额:$198.99万
-
财政年份:2017
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Core A Scientific and Administrative Integration: Thymic and peripheral Aspects of T cell Aging and Rejuvenation
-
批准号:10226916
-
项目类别:
-
资助金额:$12.2万
-
财政年份:2017
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Disparities in Immune Fitness in HIV+ Subjects with Aging
-
批准号:9203464
-
项目类别:
-
资助金额:$18.6万
-
财政年份:2016
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Longevity extension and immune function in aging (R21)
-
批准号:8842072
-
项目类别:
-
资助金额:$17.74万
-
财政年份:2014
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
IMPACT OF CMV UPON T-CELL AGING AND IMMUNE DEFENSE
-
批准号:9068437
-
项目类别:
-
资助金额:$14.31万
-
财政年份:2014
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
IMPACT OF CMV UPON T-CELL AGING AND IMMUNE DEFENSE
-
批准号:9269947
-
项目类别:
-
资助金额:$50.15万
-
财政年份:2014
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
IMPACT OF CMV UPON T-CELL AGING AND IMMUNE DEFENSE
-
批准号:9060874
-
项目类别:
-
资助金额:$45.62万
-
财政年份:2014
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Impact of CMV Upon T-Cell Aging and Immune Defense
-
批准号:9480499
-
项目类别:
-
资助金额:$6.68万
-
财政年份:2014
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
Longevity extension and immune function in aging (R21)
-
批准号:8699982
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2014
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
IMPACT OF CMV UPON T-CELL AGING AND IMMUNE DEFENSE
-
批准号:8891346
-
项目类别:
-
资助金额:$43.48万
-
财政年份:2014
-
负责人:JANKO Z. NIKOLICH
-
依托单位:
海外基金